Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 160,267 | 175,178 |
| Marketable Securities | 385,789 | N/A |
| TOTAL | $557,537 | $177,611 |
| Non-Current Assets | ||
| PPE Net | 1,955 | 209 |
| Investments And Advances | 118,857 | 0 |
| Other Non-Current Assets | 13,945 | 625 |
| TOTAL | $134,757 | $834 |
| Total Assets | $692,294 | $178,445 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 7,529 | 2,008 |
| Accrued Expenses | 37,836 | 2,994 |
| Other current liabilities | N/A | 1,400 |
| TOTAL | $46,405 | $6,911 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 9,983 | 0 |
| TOTAL | $9,983 | $N/A |
| Total Liabilities | $56,388 | $6,911 |
| Shareholders' Equity | ||
| Retained earnings | -368,668 | -219,713 |
| Other shareholders' equity | 992,593 | 390,306 |
| TOTAL | $635,906 | $171,534 |
| Total Liabilities And Equity | $692,294 | $178,445 |